The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Working at the Doherty Institute is a rich and inspiring experience. 

Current vacancies

Camera 2 Study - PhD Position

Expressions of Interest are currently being accepted for a Infectious Disease or Microbiology Fellow to condcut follow on studies from CAMERA2 as part of a PhD. 

CAMERA2 was a randomised controlled trial that compared standard therapy with standard therapy plus an anti-staphylococcal β-lactam for MRSA bacteraemia. Results were presented at ECCMID 2019 (see here).

There are several planned sub-studies and new studies that the PhD candidate could take on – some examples are below, but the candidate would have the chance to shape the proposal according to their interests. We have funded statistician support for these studies. Please direct enquiries to Steven Tong ([email protected]) or Joshua Davis ([email protected]).

This would suit a medical doctor who is interested in clinical research and who is training in infectious diseases, microbiology, renal medicine or related fields. The PhD position could be based in Melbourne, Newcastle or Darwin. A full-time candidate is preferred. Supervision would be by Steven Tong (see his Google Scholar page), and Josh Davis (see his Google Scholar page).

View more details.

The deadline for applications is Friday, 31 January 2020

Clinical Trial Manager

The Peter Doherty Institute for Infection and Immunity is a joint venture between The University of Melbourne and The Royal Melbourne Hospital, combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care in infectious diseases and immunity.

Join the leadership team as the Clinical Trial Manager to conduct a global multicentre trial in infectious diseases. The trial is led from the University of Melbourne and will recruit 6,000 patients with golden staph (Staphylococcus aureus) bloodstream infections from sites in Australia, NZ, Israel, Singapore and Canada. The trial will make use of cutting edge trial methodologies (Adaptive Platform Trial) and aims to reduce the mortality from these deadly infections.

This is an exciting opportunity for an experienced research manager to build on their research and leadership skills and take the next step in their career. 

View more details.

The deadline for applications is Wednesday, 12 February 2020

Follow us on LinkedIn and Twitter to keep up to date with opportunities at the Doherty Institute. 


T:+61 3 9035 3555
E: Doherty Reception